Postdoctoral Fellow in Preclinical Cancer Research

 

The Institute is seeking a highly talented and self-motivated postdoctoral candidate who will conduct research on preclinical phenotypic cancer cell-based screening. The candidate will develop high throughput cell-based screening technologies that use cancer progenitor cells, cancer stem cells and stromal cells derived from clinical tumor samples. The resulting technologies will be applied toward diagnostic and preclinical drug discovery platforms. The candidate should be skilled in molecular biology, biochemical and cell culture techniques. Candidate with expertise in cancer cell models and in small animal models are desirable.

 

The John Paul II Medical Research Institute (JP2MRI) seeks to find cures and therapies exclusively using a variety of adult stem cells and induced pluripotent stem cells, and does not engage in embryonic stem cell research of any kind. The JP2MRI is developing preclinical research technologies that will broadly advance drug discovery and regenerative medicine for many diseases. In addition, the Institute will engage in educational outreach to increase the number of scientists and future medical practitioners that will work with adult stem cells, always with an emphasis on medical bioethics that is consistent with the dignity of human life.

 

Candidates should have a Ph.D. in celluar and molecular biology with a qualified visa status, permanent residency or U.S. citizenship.

 

Salary is commensurate with level of experience.

© 2019 John Paul II Medical Research Institute.